Scripps Research Institute scientists have identified a mechanism through which the mitochondria of a cell control tumor aggressiveness. Based on the new findings, the team developed a simple treatment that inhibits cancer progression and prolongs life when tested in mice. The researchers, describing their work in The Journal of Clinical Investigation, note that their new approach involves drugs that are already in use for other conditions.
Led by researcher Brunhilde H. Felding (pictured), the research team looked at the mechanisms that control metastasis, the spread of cancer from its primary site to distant organs in the body. Past research suggested that mutations affecting mitochondria, which are key to energy production in cells, strongly influence whether a tumor becomes aggressive. But the mechanism was not clear.
"We decided to investigate a specific protein complex, called mitochondrial complex I, that critically determines the energy output of cellular respiration," explained co-researcher Antonio F. Santidrian. The team discovered that the balance of key metabolic cofactors processed by complex I - specifically, nicotinamide adenine dinucleotide (NAD ) and NADH, the form it takes after accepting a key electron in the energy production cycle - was disturbed in aggressive breast cancer cells.
To find out if the balance of NAD and NADH was critical for tumor cell behavior, the team proceeded to insert a yeast gene into cancer cells that caused a shift toward more NAD . To the scientists' amazement, this shift caused the tumor cells to become less aggressive. "It was a really happy moment for me," said Santidrian. But the more exciting moments, he said, were yet to come.
To confirm and extend the initial findings, the team altered genes tied to NAD production. The resulting shift again showed that higher NADH levels meant more aggressive tumors, while increased NAD had the opposite effect.
The next logical step was to find a simple way to enhance the critical NAD level therapeutically. So the team explored what would happen if mice with breast cancer were fed water spiked with nicotinamide, a precursor for NAD production. The scientists found cancer development was dramatically slowed down, and the mice lived longer. "In animal models at various stages, we see that we can actually prevent progression of the disease," said Felding.
The group is now working toward human trials to learn whether nicotinamide or other NAD precursors will have similarly impressive results in humans. Since NAD precursors are already used for other purposes, such as controlling cholesterol levels, achieving approval for human clinical trials should be simpler than is normally the case.
"It is not a totally new treatment that would need to be tested for toxicity and side effects like a new drug," said Felding. "And we already know the precursors can be easily ingested."
Such a treatment could benefit people at risk of developing aggressive breast cancer, offer complimentary treatment to chemo and radiation therapy to avoid disease recurrence, and maybe even provide a preventive treatment for women with a family history of breast cancer.
Discuss this article in our forum
Delayed treatment for breast cancer has "profound effect"
Lack of sleep a new risk factor for aggressive breast cancer
Cholesterol increases risk of breast cancer
Source: Scripps Research Institute